Skip to main content
Clinical Trials/NCT05841797
NCT05841797
Completed
Not Applicable

Piloting Risk Stratification and Tailored Interventions With Pregnant and Postpartum Women With HIV in Kenya to Prevent Disengagement From Care and Viral Failure

University of Colorado, Denver1 site in 1 country120 target enrollmentJune 5, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Human Immunodeficiency Virus
Sponsor
University of Colorado, Denver
Enrollment
120
Locations
1
Primary Endpoint
Combined retention and treatment failure outcome
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

This study includes secondary quantitative analysis, qualitative methods, and hybrid type 2 implementation-effectiveness pilot trial. The overall goal of this protocol is to determine whether risk stratification of PWLWH in conjunction with a tailored psychosocial support intervention can optimize health outcomes for the vulnerable women and infants. This study will be conducted in high-volume, low-resource health facilities in Kisumu County, Kenya, which is a priority area for research among WLWH and one of the highest HIV burden counties.

Detailed Description

Among pregnant/postpartum women living with HIV (PWLWH) in low resource, high HIV prevalence settings, access to antiretroviral treatment (ART) has increased dramatically and mother-to-child transmission (MTCT) of HIV has decreased substantially, yet successful outcomes are not universal. Despite a 52% decline in new HIV infections among children under five from 2010-2019, recent UNAIDS data indicate global targets were missed by wide margins, with an estimated 160,000 new pediatric HIV infections annually. Sub-optimal retention of PWLWH is a major contributor to new pediatric infections. This study will be conducted in high-volume, low-resource health facilities in Kisumu County, Kenya, which is a priority area for research among WLWH and one of the highest HIV burden counties. As PMTCT programs in sub-Saharan Africa (SSA) aim for the elimination of MTCT in the context of decreased funding, there is need for research geared towards identifying and supporting the most vulnerable PWLWH with tailored interventions that can be implemented using available resources. This study aims to build on a previous study, Mother and Infant Visit Adherence and Treatment Engagement Study (MOTIVATE, R01HD080477), to develop and implement interventions that can promote proper taking of HIV drugs among PWLWH, namely a risk calculator to identify women at high risk for treatment failure and an adapted Problem Management Plus (PM+) intervention specifically geared towards women identified as high risk. Such interventions are critical in order to identify the most vulnerable PWLWH as early as possible to intervene with effective targeted interventions that will help improve maternal and child health outcomes.

Registry
clinicaltrials.gov
Start Date
June 5, 2023
End Date
August 12, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Imminent plans of suicide and severe impairment due to severe mental, neurological or substance use disorders
  • Less than 15 years of age
  • Less than 20 weeks estimated gestational age or not currently pregnant
  • Not HIV-infected at time of first ANC visit

Outcomes

Primary Outcomes

Combined retention and treatment failure outcome

Time Frame: Baseline, 3 months postpartum, 6 months postpartum

Failure will be outcome of a missed visit (\>30 days) OR treatment failure (elevated VL\>= 200 copies/ml among PWLWH assessed through medical records from baseline to 6 months postpartum.

Secondary Outcomes

  • Fidelity - Content(6 months postpartum)
  • Feasibility - Recruitment(Enrollment)
  • Fidelity - Coverage(6 months postpartum)
  • Acceptibility(6 months postpartum)
  • Depression(Baseline, 3 months postpartum, 6 months postpartum)
  • Psychological Outcome Profiles(Baseline, 3 months postpartum, 6 months postpartum)

Study Sites (1)

Loading locations...

Similar Trials